New drug aims to get heart surgery patients home sooner
Disease control
Not yet recruiting
This trial is testing a new drug called EA-230 to see if it helps people recover faster after heart bypass surgery. The goal is to shorten the time patients need to stay in the hospital and intensive care unit (ICU) and reduce serious complications. About 300 adults scheduled for…
Phase: PHASE3 • Sponsor: EBI Anti Sepsis BV • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC